September 25, 2020

Indianapolis Regional Healthcare Compliance Conference

Virtual , Eastern Daylight Time (EDT)

Registration closed
View all past conferences

Handouts

Overall Survey | CEU Application | Conference Brochure

Research and Big Data

Moderator:
Carl McKinley Privacy and Compliance Officer Regenstrief Institute

Panelists:
Mitch Parker CISO, Indiana University Health
Dr. Shaun Grannis VP Data and Analytics at Regenstrief Institute and Regenstrief Chair in Medical Information, Indiana University School of Medicine
Stanley Crosley Principal at Crosley Law Offices, LLC and Director, Indiana University Center for Law, Ethics, and Applied Research in Health Information

• What are your concerns about using AI in healthcare?
• How is AI already being used in healthcare? • What do you want compliance to understand about AI?
• What is bias in AI and how does bias effect AI?

No Presentation Available
Evaluation

Telehealth: The New Normal

Nicholas Merker Partner Ice Miller

• How health care professionals are adapting away from the in-person visit and to telehealth from a business perspective
• What does telehealth compliance look like and how do professionals prepare for the inevitable withdrawal of OCR’s leniency enforcement period after COVID-19
• Billing compliance issues in a telehealth world

Presentation
Evaluation

Perspectives of Compliance Officers: How to Thrive as a Compliance Officer

Moderator:
Jasmin N. French Senior Manager – Ethics & Compliance Cummins, Inc.
Panelists:
Steve Guymon Senior Advisor, Ethics and Compliance Elie Lilly and Company
Clarice McCauley Assistant General Counsel, Ethics & Compliance Roche Diagnostics Corporation
Lisa M. Martin Chief Compliance Officer Indiana University Health
• Identify tactics for collaboration with business leaders
• Assess organizational risk and remediation
• Drive professionalism and continuous improvement in the ethics and compliance program

No Presentation Available
Handout 1
Handout 2
Evaluation

Pharmacy Compliance

Christopher T. Dang Associate Quarles & Brady

• Understanding the status of coronavirus-related pharmacy changes
• Identifying new requirements for pharmacy compliance, including controlled substances
• Understanding strategies to prepare for and appeal pharmacy audits, and how the compliance program can support positive audit outcomes

Presentation
Evaluation

OIG Mandated Six-Year Look Back Audits

Chad Eckhardt Partner and Chair - Healthcare Innovation Team, Frost Brown Todd LLC
James Rose Managing Director SunHawk Consulting LLC

• Learn to Apply Use of Statistical Sampling and Extrapolation
• Understand Recent Updates and Perspectives
• Apply Drivers of Efficient and Diligent Analysis

Presentation
Evaluation

Measuring the Effectiveness of a Compliance Program Using the DOJ Guidance

Joseph Zielinski Senior Counsel Wooden McLaughlin LLP

• How to analyze the three “fundamental questions” that pursuant to Department of Justice guidance should be asked to determine the effectiveness of a compliance program
• How to apply and reference other compliance guidance to the Department of Justice’s three “fundamental questions”
• How to assess the effectiveness of a compliance program using the DOJ’s guidance, which specifically calls out various elements associated with a compliance program and what questions to ask to assess these elements (tool provided to assist in this assessment)

Presentation
Handout 1
Handout 2
Evaluation